1,520 Alzheimers Headlines
Patricio Reyes M.D., F.A.N.N.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

Barrow Neurological Institute
St. Joseph's Hospital and Medical Center
"2 NEW THERAPIES FOR ALZHEIMER'S"
Produced by MD Health Channel
Executive Editor.....Anne-Merete Robbs
CEO..............Stan Swartz

Dr. Reyes and his team are constantly working on new medicines and new solutions...You will receive news alerts...information on new trials as Dr Reyes announces them!
"2 NEW THERAPIES FOR ALZHEIMER'S"
Patricio Reyes M.D., F.A.N.N.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

St. Joseph's Hospital and Medical Center



DO YOU HAVE ALZHEIMERS?
 
"HELP DR. REYES... IN HIS BATTLE TO FIND A CURE...
.HE NEEDS YOUR HELP:
YOU CAN HELP WIN THE BATTLE FOR A CURE BY JOINING A TRIAL!!"....

Stan Swartz, CEO,
The MD Health Channel



"You'll receive all medication and study based procedures at
no charge

if you qualify for one of the many trials being conducted at Barrow Neurological Institute."
 

"Dr. Reyes Changed My Life"

- John Swartz
92 Years Old
Attorney at Law
"Dr.Reyes Changed My Life "
1:18
"At 92...I had lost my will to live"
5:48
Tips on Aging
2:29
"Dr. Reyes gave me customized health care"
2:09

Patricio Reyes M.D.
Director, Traumatic Brain Injury, Alzheimer's Disease & Cognitive Disorders Clinics; Phoenix, AZ; Chief Medical Officer, Retired NFL Players Association

Barrow Neurological Institute

St. Joseph's Hospital and Medical Center
"PRESERVING BRAIN FUNCTIONS "
Runtime: 50:22
Runtime: 50:22
"2 NEW THERAPIES FOR ALZHEIMER'S"
Runtime: 10:27
Runtime: 10:27
ALZHEIMER'S AWARENESS PROGRAMS
Runtime: 5:00
Runtime: 5:00
BIOMEDICAL RESEARCH IN ALZHEIMER'S DISEASE
PDF Document 850 kb

Download Free

4 TALES OF NEUROSURGERY &
A PIANO CONCERT BY DR. SPETZLER...
Plus 2 books written by Survivors for Survivors!
Robert F. Spetzler M.D.
Director, Barrow Neurological Institute

J.N. Harber Chairman of Neurological Surgery

Professor Section of Neurosurgery
University of Arizona
TALES OF NEUROSURGERY:
A pregnant mother..a baby..faith of a husband.. .plus... Cardiac Standstill: cooling the patient to 15 degrees Centigrade!
Lou Grubb Anurism
The young Heros - kids who are confronted with significant medical problems!
2 Patients...confronted with enormous decisions before their surgery...wrote these books to help others!
A 1 MINUTE PIANO CONCERT BY DR. SPETZLER

Michele M. Grigaitis MS, NP
Alzheimer's Disease and Cognitive Disorders Clinic

Barrow Neurological Clinics
COPING WITH DEMENTIA
 
Free Windows Media Player Click

Links
Barrow Neurological Institute

Archives
October 2006  
November 2006  
December 2006  
January 2007  
February 2007  
March 2007  
May 2007  
June 2007  
November 2007  
December 2007  
April 2008  
July 2008  
August 2008  
September 2008  
October 2008  
November 2008  
December 2008  
January 2009  
February 2009  
March 2009  
April 2009  
May 2009  
February 2010  
March 2013  
May 2013  
November 2013  
January 2014  
February 2014  
March 2014  
April 2014  
May 2014  
June 2014  
July 2014  
June 2016  
July 2016  
August 2016  
September 2016  
October 2016  
November 2016  
December 2016  
January 2017  
February 2017  
March 2017  
April 2017  
May 2017  
June 2017  
July 2017  
August 2017  
September 2017  
October 2017  
November 2017  
December 2017  
January 2018  
February 2018  

This page is powered by Blogger. Isn't yours?

Friday, July 18, 2014

 

Arthritis drug Etanercept could also halt Alzheimer's

A safe and widely-used arthritis drug stops Alzheimer’s in its tracks, a British study has found.

The 20 men and women who were given Etanercept did not descend further into the disease – unlike those who were given a dummy treatment. Memory, mood and the ability to carry out vital everyday tasks such as washing and dressing were all, on average, stopped from getting worse.

The results, revealed at a major Alzheimer’s conference and dubbed ‘quite amazing’, are comparable with those for Aricept, one of the few existing Alzheimer’s treatments.

However, Aricept and other drugs do not work for everyone and their effects wear off relatively quickly.

With Alzheimer’s and other forms of dementia affecting more than 800,000 Britons and the number predicted to double in a generation as the population ages, David Cameron has described dementia as ‘the key health challenge of this generation’.

A drug already used for something else would be cheaper and quicker to test and get to patients.

Dr Doug Brown, director of research and development at the Alzheimer’s Society, said: ‘There is a desperate unmet need for new drugs for dementia but we know that getting treatments to market from scratch can cost billions and take decades.

‘Repurposing existing drugs could see new treatments for dementia available in a fraction of the time and at a fraction of the cost, so it is an opportunity we can’t afford to waste.’

The study by Professor Clive Holmes, a psychiatrist and Alzheimer’s researcher, focuses on a blood protein called TNFα, which is key to the pain, inflammation and destruction of the joints in rheumatoid arthritis.

It is also thought to trigger the death of brain cells in Alzheimer’s – and patients with more of it in their blood do worse than those with low levels.

Etanercept, which is injected into the stomach or thigh, stops TNFα from causing damage.

And given as a weekly jab for six months, it held Alzheimer’s at bay for that time, the Alzheimer’s Association International Conference in Copenhagen heard.

Professor Holmes cautioned that only a small number of patients were treated – but described the results as ‘quite amazing’.

He said: ‘Our results are better than we expected.

‘It is the first drug in a long time that has shown such promise.’

The professor is now seeking funding for a larger trial.

Many promising Alzheimer’s drugs fail when tested on hundreds and thousands of people (PLEASE KEEP) but if the drug fulfils its early promise, it could be given to dementia patients in as little as five years.

So far it has only been given to Alzheimer’s patients for six months. But it is hoped that given for longer, it would stall the disease for longer.

It may even prevent someone with slight memory lapses ever going to suffer full-blown Alzheimer’s.

Professor Holmes said: ‘We are not reversing the disease but we may be holding it back, so the earlier we start it the better.’

However, he stressed that much more research is needed.

Dr Eric Karran, of Alzheimer’s Research UK, described the results as ‘encouraging’ but cautioned: ‘We know that clinical trials have a high failure rate and so we need to see Etanercept tested further in larger and longer trials in Alzheimer’s disease.’

The jab costs around £180 a week. However, it is hoped that by the time it is cleared for use in Alzheimer’s, the price will have fallen. It may also be available in pill form by then.

http://www.dailymail.co.uk/health/article-2695017/Arthritis-drug-halt-Alzheimer-s-Treatment-stop-progression-memory-loss-poor-mood.html